Thermogenesis Expects PMA Approval For CryoSeal Sealant By Year’s End
This article was originally published in The Gray Sheet
Executive Summary
Thermogenesis plans to market its CryoSeal FS fibrin sealant system to large surgery hospitals immediately upon FDA approval, expected in late 2006
You may also be interested in...
Stem Cell Therapy Needs More Than Just The Cells: Device Firms See Opening
The advent of stem cell therapy to future medicine will be facilitated by medical devices that actually process and store the cells. At least two firms already see near-term opportunities to pioneer the technology
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.